Medigene (MDG1) News Today → Global crypto currency reset (41 major banks signed up) (From Stansberry Research) (Ad) Free MDG1 Stock Alerts €1.44 0.00 (0.00%) (As of 05/10/2024 ET) Add Compare Share Share HeadlinesStock AnalysisChartHeadlinesStock AnalysisChartHeadlines All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineMedigene Presents Superior TCR-T Cell Functionality by Inclusion of a Costimulatory Switch Proteinmarkets.businessinsider.com - May 2 at 6:34 AMMedigene AG reports Financial Results and Business Update for Q1 2024finance.yahoo.com - April 26 at 10:17 AMMedigene presents streamlined 6-day, high stemness TCR-T therapy production processfinance.yahoo.com - April 25 at 9:58 AMPTA-Adhoc: Medigene AG: Medigene AG führt Bezugsrechtskapitalerhöhung mit Backstop-Vereinbarung durchfinanznachrichten.de - April 22 at 7:28 PMMedigene to Present at Upcoming Scientific Conferencesfinance.yahoo.com - April 17 at 10:16 AMMedigene Presents Favorable Safety Profile of TCR-T Cells with Costimulatory Switch Protein at AACR Annual Meeting 2024finance.yahoo.com - April 8 at 10:13 AMMedigene: 2024 steht im Zeichen von MDG1015, BioNTech und der Finanzierungfinanznachrichten.de - April 4 at 8:13 PMPTA-News: Medigene AG: Medigene AG sichert sich europäisches Patent für ihre iM-TCR-Technologiefinanznachrichten.de - April 4 at 8:43 AMMedigene AG Secures European Patent for its iM-TCR Technologyfinance.yahoo.com - April 4 at 8:43 AMPTA-News: Medigene AG: Medigene AG gibt Finanzergebnisse für das Geschäftsjahr 2023 und Unternehmens-Update bekanntfinanznachrichten.de - March 28 at 7:38 PMPTA-News: Medigene AG: Medigene AG gibt -2-finanznachrichten.de - March 28 at 8:39 AMWe Think Medigene (ETR:MDG1) Needs To Drive Business Growth Carefullyfinance.yahoo.com - March 26 at 5:47 AMPTA-News: Medigene AG: Medigene AG nimmt an der H.C. Wainwright 2nd Annual Cell Therapy Virtual Conference teilfinanznachrichten.de - March 19 at 12:38 PMPTA-News: Medigene AG: Medigene AG veröffentlicht Finanzergebnisse für das Geschäftsjahr 2023 am 28. März 2024finanznachrichten.de - March 18 at 4:35 PMMedigene AG to report full year 2023 financial results on March 28, 2024finance.yahoo.com - March 18 at 4:35 PMMedigene to Present Favorable Safety Profile of TCR-T Cells upon Addition of Costimulatory Switch Protein with a Poster Presentation at AACR 2024 Annual Meetingfinance.yahoo.com - March 6 at 4:20 PMPTA-News: Medigene AG: Medigene erweitert Patentportfolio in Japan um iM-TCR-Technologie zur Kontrolle der TCR-T-Sicherheit und -Wirksamkeitfinanznachrichten.de - March 4 at 8:22 AMMedigene AG: Medigene Presents at CAR-TCR Summit Europe Showcasing Unique Approach for Development of Differentiated TCR-T Therapiesfinanznachrichten.de - February 29 at 1:39 PMPTA-News: Medigene AG: Medigene zeigt auf dem CAR-TCR Summit Europe innovative Ansätze zur Entwicklung differenzierter TCR-T-Therapienfinanznachrichten.de - February 29 at 8:39 AMMedigene Presents at CAR-TCR Summit Europe Showcasing Unique Approach for Development of Differentiated TCR-T Therapiesmarkets.businessinsider.com - February 29 at 8:39 AMPTA-News: Medigene AG: Medigene präsentiert auf folgenden Konferenzenfinanznachrichten.de - February 19 at 8:53 AMMedigene to Present at Upcoming Conferencesfinance.yahoo.com - February 19 at 8:53 AMPTA-News: Medigene AG: Medigene gibt Auswahl der Anwendungsgebiete für die klinische Entwicklung der TCR-T-Therapie bei soliden Tumoren bekanntfinanznachrichten.de - February 12 at 1:18 PMMedigene AG: Medigene Announces Indication Selection for the Clinical Development of its Lead 3rd Generation TCR-T Therapy Program in Solid Tumorsfinanznachrichten.de - February 12 at 1:18 PMMedigene Announces Indication Selection for the Clinical Development of its Lead 3rd Generation TCR-T Therapy Program in Solid Tumorsuk.finance.yahoo.com - February 12 at 8:17 AMMedigene Announces Indication Selection for the Clinical Development of its Lead 3rd Generation TCR-T Therapy Program in Solid Tumorsfinance.yahoo.com - February 12 at 8:17 AMMedigene AG Namen-Akt. nach Kapitalherabsetzungmorningstar.com - January 2 at 1:59 PMPTA-News: Medigene AG: Medigene AG nimmt an der 42. Jahrestagung der J.P. Morgan Healthcare Conference teilfinanznachrichten.de - December 19 at 9:58 AMMedigene AG to attend at the 42nd Annual J.P. Morgan Healthcare Conferencefinance.yahoo.com - December 19 at 9:58 AMMedigene amends 2023 financial guidancefinance.yahoo.com - November 21 at 2:48 PMMedigene AG Announces Prioritization of Pipeline and Resource Allocation as well as Extension of Cash Runwayfinance.yahoo.com - November 21 at 2:48 PMMedigene presents new data for MDG2011, the first TCR in a novel KRAS library, demonstrating capability of its proprietary E2E Platform to generate multiple enhanced TCR-T therapies against mKRAS G12V A*11finance.yahoo.com - November 4 at 1:38 PMMedigene Reports Financial Results and Corporate Update for Q3 2023finance.yahoo.com - October 26 at 7:35 AMMedigene AG (MDG1.HA)finance.yahoo.com - October 25 at 8:32 PMAGC Biologics Signs TCR-T Cell Services Agreement to Support Medigene’s New Cell Therapy Productfinance.yahoo.com - October 25 at 8:30 AMPTA-News: Medigene AG: Medigene stellt erste präklinische Daten zu mKRAS G12V kombiniert mit dem PD1-41BB kostimulatorischen Switch-Protein vorfinanznachrichten.de - October 24 at 4:28 AMPTA-News: Medigene AG: Medigene stellt erste -2-finanznachrichten.de - October 23 at 5:36 AMMedigene presents first pre-clinical data of optimal affinity TCR targeting mKRAS G12V combined with a PD1-41BB costimulatory switch protein showing enhanced and sustained tumor killingfinance.yahoo.com - October 23 at 5:36 AMMedigene to present new pre-clinical data for pipeline TCR-T therapies at the ESMO Congress 2023finance.yahoo.com - October 16 at 1:02 PMWe're Keeping An Eye On Medigene's (ETR:MDG1) Cash Burn Ratefinance.yahoo.com - October 15 at 10:04 AMMedigene AG Secures European Patent for its PD1-41BB Costimulatory Switch Proteinfinance.yahoo.com - September 27 at 9:50 AMMedigene AG Secures European Patent for its PD1-41BB Costimulatory Switch Proteinfinance.yahoo.com - September 27 at 9:50 AMPTA-News: Medigene AG: Medigene AG gibt Auswahl des Leitkandidaten für MDG2011 und damit die erste TCR-T-Therapie ihrer KRAS-Bibliothek bekanntfinanznachrichten.de - September 18 at 12:59 PMMedigene AG Announces Lead Selection for MDG2011 Representing the First TCR-T Therapy of its KRAS Libraryfinance.yahoo.com - September 18 at 12:59 PMPTA-News: Medigene AG: Medigene AG präsentiert auf der Baader Investment Conference 2023finanznachrichten.de - September 11 at 6:50 PMMedigene AG to present at the Baader Investment Conference 2023finance.yahoo.com - September 11 at 6:50 PMPTA-News: Medigene AG: Medigene AG präsentiert auf der 25. H.C. Wainwright Annual Global Investment Conferencefinanznachrichten.de - September 5 at 6:22 PMMedigene AG to present at the H.C. Wainwright 25th Annual Global Investment Conferencefinance.yahoo.com - September 5 at 6:22 PMMedigene AG: Medigene presents rationale for combining its 3S TCRs with enhancement tools as an approach to improve clinical outcomesfinanznachrichten.de - August 31 at 2:58 PMPTA-News: Medigene AG: Medigene zeigt Konzept für -2-finanznachrichten.de - August 30 at 6:59 PM Get Medigene News Delivered to You Automatically Sign up to receive the latest news and ratings for MDG1 and its competitors with MarketBeat's FREE daily newsletter. Email Address He Is Giving Away Bitcoin (Ad)And my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a very important time to pay attention to what we are doing and what is happening. If you wait... it will be too late. This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin. >> Register right here MDG1 Media Mentions By Week MDG1 Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. MDG1 News Sentiment▼0.000.52▲Average Medical News Sentiment MDG1 News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. MDG1 Articles This Week▼01▲MDG1 Articles Average Week Get Medigene News Delivered to You Automatically Sign up to receive the latest news and ratings for MDG1 and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Genfit News Today MorphoSys News Today Fielmann Group News Today Fresenius SE & Co. KGaA News Today Sanofi News Today Sartorius Aktiengesellschaft News Today Sartorius Stedim Biotech News Today Drägerwerk AG & Co. KGaA News Today Stratec News Today CompuGroup Medical SE & Co. KGaA News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (ETR:MDG1) was last updated on 5/11/2024 by MarketBeat.com Staff From Our PartnersThe Crypto 9-5 Escape PlanCrypto 101 MediaDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsGlobal crypto currency reset (41 major banks signed up)Stansberry ResearchForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressHow Biden has already won 2024Porter & CompanyRSVP: Charles Payne’s Cash Flow WorkshopUnstoppable ProsperityThe “Next Bitcoin”? 10 CENT Crypto Set to ExplodeTrue Market InsidersThe ONE AI Stock to own now. (It’s not Nvidia.)Weiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Medigene AG Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
